INGN Sep 2019 110.000 call

OPR - OPR Delayed Price. Currency in USD
0.1700
0.0000 (0.00%)
As of 9:59AM EDT. Market open.
Stock chart is not supported by your current browser
Previous Close0.1700
Open0.1700
Bid0.0000
Ask0.1000
Strike110.00
Expire Date2019-09-20
Day's Range0.1700 - 0.1700
Contract RangeN/A
Volume3
Open InterestN/A
  • Motley Fool

    Winners and Losers in Healthcare This Quarter

    ShockWave and Guardant reported fantastic things, while Abiomed and Inogen dropped precipitously on some scary updates.

  • Motley Fool

    Is Resmed a Buy?

    The CPAP pioneer has a phenomenal track record of success, but should investors jump on board today?

  • Motley Fool

    Inogen Is Packed With Potential

    The innovative oxygen therapy company has grown like gangbusters in recent years and is staring down a massive opportunity.

  • Is Now An Opportune Moment To Examine Inogen, Inc. (NASDAQ:INGN)?
    Simply Wall St.

    Is Now An Opportune Moment To Examine Inogen, Inc. (NASDAQ:INGN)?

    Inogen, Inc. (NASDAQ:INGN), which is in the medical equipment business, and is based in United States, received a lot...

  • Motley Fool

    3 More Medtech Stocks for Your Watch List

    These three companies are pumping fresh air into the lungs of millions all over the world.

  • Inogen (INGN) Q2 Earnings Miss Estimates, 2019 View Lowered
    Zacks

    Inogen (INGN) Q2 Earnings Miss Estimates, 2019 View Lowered

    Inogen (INGN) gains from international revenues in Q2; slashes 2019 guidance.

  • Inogen Inc (INGN) Q2 2019 Earnings Call Transcript
    Motley Fool

    Inogen Inc (INGN) Q2 2019 Earnings Call Transcript

    INGN earnings call for the period ending June 30, 2019.

  • Why Inogen Shareholders Are Having Another Tough Day
    Motley Fool

    Why Inogen Shareholders Are Having Another Tough Day

    Shares sink after the medical-device maker reported weak second-quarter results and slashed guidance. Again.

  • Inogen (INGN) Misses Q2 Earnings and Revenue Estimates
    Zacks

    Inogen (INGN) Misses Q2 Earnings and Revenue Estimates

    Inogen (INGN) delivered earnings and revenue surprises of -10.00% and -5.55%, respectively, for the quarter ended June 2019. Do the numbers hold clues to what lies ahead for the stock?

  • Business Wire

    Inogen Announces Second Quarter 2019 Financial Results and Updates 2019 Guidance

    – Q2 2019 Record Total Revenue of $101.1 million –

  • Benzinga

    Earnings Preview: Inogen

    Inogen (NASDAQ: INGN ) announces its next round of earnings this Wednesday, August 7. Here is Benzinga's everything-that-matters guide for the Q2 earnings announcement. Earnings and Revenue Analysts covering ...

  • Earnings Preview: Inogen (INGN) Q2 Earnings Expected to Decline
    Zacks

    Earnings Preview: Inogen (INGN) Q2 Earnings Expected to Decline

    Inogen (INGN) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.

  • Business Wire

    Inogen to Announce Second Quarter 2019 Financial Results on Wednesday, August 7, 2019

    Inogen, Inc. , a medical technology company offering innovative respiratory products for use in the homecare setting, announced that it will release second quarter 2019 financial results before market open on Wednesday, August 7, 2019.

  • 3 Top Healthcare Stocks to Buy in July
    Motley Fool

    3 Top Healthcare Stocks to Buy in July

    Find out which stocks have our team of healthcare experts feeling excited right now.

  • Markit

    See what the IHS Markit Score report has to say about Inogen Inc.

    Inogen Inc NASDAQ/NGS:INGNView full report here! Summary * ETFs holding this stock have seen outflows over the last one-month * Bearish sentiment is moderate * Economic output for the sector is expanding but at a slower rate Bearish sentimentShort interest | PositiveShort interest is moderate for INGN with between 5 and 10% of shares outstanding currently on loan. The last change in the short interest score occurred more than 1 month ago and implies that there has been little change in sentiment among investors who seek to profit from falling equity prices. Money flowETF/Index ownership | NegativeETF activity is negative. Over the last one-month, outflows of investor capital in ETFs holding INGN totaled $65.09 billion. Additionally, the rate of outflows appears to be accelerating. Economic sentimentPMI by IHS Markit | NegativeAccording to the latest IHS Markit Purchasing Managers' Index (PMI) data, output in the Healthcare sector is rising. The rate of growth is weak relative to the trend shown over the past year, however, and is easing. Credit worthinessCredit default swapCDS data is not available for this security.Please send all inquiries related to the report to score@ihsmarkit.com.Charts and report PDFs will only be available for 30 days after publishing.This document has been produced for information purposes only and is not to be relied upon or as construed as investment advice. To the fullest extent permitted by law, IHS Markit disclaims any responsibility or liability, whether in contract, tort (including, without limitation, negligence), equity or otherwise, for any loss or damage arising from any reliance on or the use of this material in any way. Please view the full legal disclaimer and methodology information on pages 2-3 of the full report.

  • Here’s What Hedge Funds Think About Inogen Inc (INGN)
    Insider Monkey

    Here’s What Hedge Funds Think About Inogen Inc (INGN)

    Reputable billionaire investors such as Jim Simons, Cliff Asness and David Tepper generate exorbitant profits for their wealthy accredited investors (a minimum of $1 million in investable assets would be required to invest in a hedge fund and most successful hedge funds won't accept your savings unless you commit at least $5 million) by pinpointing […]

  • Here's Why I Think Inogen (NASDAQ:INGN) Is An Interesting Stock
    Simply Wall St.

    Here's Why I Think Inogen (NASDAQ:INGN) Is An Interesting Stock

    Some have more dollars than sense, they say, so even companies that have no revenue, no profit, and a record of...

  • GlobeNewswire

    Bragar Eagel & Squire is Investigating Certain Officers and Directors of Inogen, Health Insurance Innovations, Amyris and Nutanix and Encourages Investors to Contact the Firm

    Bragar Eagel & Squire is investigating certain officers and directors of Inogen, Inc., Health Insurance Innovations, Inc., Amyris, Inc., and Nutanix, Inc. More information about each potential case can be found at the link provided. Bragar Eagel and Squire is investigating certain officers and directors of Inogen following a class action complaint that was filed against Inogen on March 6, 2019.

  • 2 Falling Knives With No Debt
    GuruFocus.com

    2 Falling Knives With No Debt

    Warning! GuruFocus has detected 3 Warning Signs with IRDM. The risk is very high with this kind of investment, but if investors look for companies that have no debt and a moderate to high current ratio, the risk can be significantly decreased. In addition, the companies have received an overweight recommendation rating from Wall Street, increasing the chances of a successful bet as these stocks are expected to outperform their industries within 12 months.

  • Is Inogen, Inc. (NASDAQ:INGN) Creating Value For Shareholders?
    Simply Wall St.

    Is Inogen, Inc. (NASDAQ:INGN) Creating Value For Shareholders?

    Today we'll look at Inogen, Inc. (NASDAQ:INGN) and reflect on its potential as an investment. To be precise, we'll...

  • Inogen (INGN) Down 6.8% Since Last Earnings Report: Can It Rebound?
    Zacks

    Inogen (INGN) Down 6.8% Since Last Earnings Report: Can It Rebound?

    Inogen (INGN) reported earnings 30 days ago. What's next for the stock? We take a look at earnings estimates for some clues.

  • Business Wire

    Inogen Announces Participation in 39th Annual William Blair Growth Stock Conference

    Inogen, Inc. , a medical technology company offering innovative respiratory products for use in the homecare setting, today announced that the Company’s management will be participating in the 39th Annual William Blair Growth Stock Conference in Chicago.